comprehensive -WSS

comprehensive

author：focus 2025-09-30 18:16:53 - browse：21535

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital. We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions.

For more on what we cover, here’s the news on Dewpoint Therapeutics; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： United colonoscopy coverage change 'may cost lives,' doctors say

leisure time

WSS

Sports medicine is finally prioritizing gender equality

How should state employee insurance handle Wegovy?

European regulators consider appeal over Amylyx ALS drug

Guidelines to prevent youth baseball injuries need more muscle

European regulators recommend Amylyx's ALS drug be rejected

Life sciences deals on track to hit lowest point since 2017

hotspot

comprehensive

explore

What does generative AI mean for health care? We asked experts

How doctors and nurses shape Google's AI

Medical leaders decry Supreme Court decision on affirmative action

Takeaways from AdvaMed, the largest medical devices conference

Guidelines to prevent youth baseball injuries need more muscle

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

DIEP, the 'gold standard' of breast reconstruction, is under threat

Jerome Adams on the need for new antivirals for Covid

hotspot

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

Drug repurposing or repositioning? The language matters

Hepatitis C has a cure — but many Americans still lack access to it

STAT Readout: Today's biotech news includes Sana and Amylyx

What's changing in Medicare's open enrollment this year?

leisure time

focus

focus

explore